← Home / AVANOS MEDICAL, INC. (AVNS)
Stock Analysis
AVANOS MEDICAL, INC. (AVNS)
AVNS
AVNS · Market data
24.99 +0.04%
Track AVNS in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when AVNS price is:
52W Range Position
100%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-02 16:44 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 25.05. Holding above 24.90 keeps the current thesis intact.
⚖️
Fundamentals
Improving / Improving
Price Structure
Constructive
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
24.90
Break Above
Confirmation improves above resistance.
25.05
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below 24.90
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
30
Listing Compliance
HIGH
AVNS listing compliance update
On the Closing Date, Merger Subsidiary, as initial borrower, entered into a Credit Agreement (the “Credit Agreement”), with A-AV Acquireco, Inc., a Delaware corporation, as a borrower (“A-AV Acquireco Borrower” and together with the Company, the “Borrowers” and each, a “Borrower”), A-AV Intermediateco, LP, a Delawar...
8-K Filing SEC EDGAR
JUL
30
$
Debt Financing
HIGH
AVNS debt financing update
On the Closing Date, Merger Subsidiary, as initial borrower, entered into a Credit Agreement (the “Credit Agreement”), with A-AV Acquireco, Inc., a Delaware corporation, as a borrower (“A-AV Acquireco Borrower” and together with the Company, the “Borrowers” and each, a “Borrower”), A-AV Intermediateco, LP, a Delawar...
8-K Filing SEC EDGAR
JUL
30
Material Agreement
HIGH
AVNS material agreement
Termination of a Material Definitive Agreement Concurrently with the closing of the Merger on the Closing Date, and in connection with the entry into the Credit Agreement, the Company repaid all loans and terminated all credit commitments outstanding under that certain Credit Agreement, dated as of June 24, 2022, by...
8-K Filing SEC EDGAR
What's Driving AVNS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 25.05 for confirmation and 24.90 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 24.90
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
62.1
Price Chart
AVNS — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Loss
Earnings not meaningful
Earnings are negative or not useful, so sales, book value and cash-flow metrics matter more.
Market Cap
$1.2B
Company size
EV
$1.2B
Debt-adjusted value
P/E
-15.7
Not meaningful
P/S
1.6
Low sales multiple
P/B
1.5
Low book multiple
EV/Sales
1.7
Low sales multiple
EV/EBIT
-19.0
Not meaningful
P/FCF
33.2
Reasonable
FCF Yield
3.01%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Improving business, cash flow needs monitoring
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
Revenue Growth
Improving
Profitability
Improving
Cash Flow
Pressured
Balance Sheet
Manageable
💵 Revenue
182.20M
↗ Improving
📈 Net Income
5.10M
↗ Improving
🧮 EPS (Basic)
0.11
↗ Improving
AVANOS MEDICAL, INC.